Atea Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
20 Jun 24 | SellUS$61,144 | Bruce Polsky | Individual | 17,544 | US$3.49 | |
05 Jun 24 | SellUS$4,024 | Jean-Pierre Sommadossi | Individual | 1,006 | US$4.00 | |
27 Nov 23 | BuyUS$1,258,521 | Tang Capital Management, LLC | Company | 433,463 | US$3.01 |
Insider Trading Volume
Insider Buying: AVIR insiders have only sold shares in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 8,119,669 | 9.64% |
Hedge Funds | 11,682,571 | 13.9% |
General Public | 21,523,668 | 25.6% |
Institutions | 42,897,192 | 50.9% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
9,243,306 | US$36.0m | -2.12% | no data | |||
6,145,861 | US$24.0m | -12.2% | 0.64% | |||
6,040,551 | US$23.6m | -0.02% | no data | |||
5,779,029 | US$22.5m | 8.01% | no data | |||
5,536,710 | US$21.6m | 1.37% | 12.13% | |||
4,722,522 | US$18.4m | 2.67% | no data | |||
4,076,741 | US$15.9m | 0% | 1.75% | |||
2,485,638 | US$9.7m | 0% | 0.96% | |||
1,882,480 | US$7.3m | 4.12% | no data | |||
1,678,383 | US$6.5m | 2.97% | no data | |||
1,123,400 | US$4.4m | -24.9% | 0.01% | |||
962,458 | US$3.8m | 0% | 0.01% | |||
811,503 | US$3.2m | 4.26% | no data | |||
687,269 | US$2.7m | -3.41% | no data | |||
672,984 | US$2.6m | 22.2% | 0.01% | |||
670,208 | US$2.6m | 0% | no data | |||
612,319 | US$2.4m | 0% | no data | |||
577,400 | US$2.3m | 81% | 0.01% | |||
571,359 | US$2.2m | -4.08% | 0.01% | |||
400,000 | US$1.6m | -21.3% | 0.22% | |||
382,932 | US$1.5m | 315% | no data | |||
372,250 | US$1.5m | 130% | no data | |||
350,004 | US$1.4m | 0% | no data | |||
345,077 | US$1.3m | 0% | 0.01% | |||
289,493 | US$1.1m | 0% | no data |